Effect of Processed Honey and Royal Jelly on Cancer-Related Fatigue
A Double-Blind Randomized Clinical Trial
Keywords:
Fatigue, Cancer, Royal jellyAbstract
Background: Cancer-related fatigue (CRF) is experienced by 50% to 90% of cancer patients and can severely affect their quality of life and functional capacity. Several randomized trials have recommended various ways to alleviate the symptoms of CRF with or without recourse to medications.
Objective: The aim of this study is to evaluate the effectiveness of processed honey and royal jelly on the symptoms of CRF in cancer patients who are undergoing hormone therapy, chemotherapy, chemo-radiation, or radiotherapy.
Methods: Fifty-two participants from the patients who visited the oncology clinic of Shohada-e-Tajrish hospital in Tehran (Iran) between May 2013 and August 2014 were selected and divided into two groups. The study group (26 patients) received processed honey and royal jelly, while the control group received pure honey. Both groups were instructed to consume their 5mL supplement twice daily for 4 weeks. Both groups were assessed at the beginning of the study, after 2 weeks, and then at the end of 4 weeks of treatment. Fatigue was measured using a visual analogue fatigue scale (VAFS) and fatigue severity scale (FSS). The results were compared between the two arms of study, and equality of probability distributions was assessed using a Kolmogorov–Smirnov test.
Results: The mean age of the 52 patients was 54.84. After two and four weeks of treatment with processed honey and royal jelly, VAFS and FSS due to treatment was better in the study group than in the control group, and the differences were statistically significant (p<0.001, p<0.001, respectively).
Conclusion: To the best of our knowledge, our study provided support for the use of processed honey and royal jelly to ameliorate CRF. The positive results of this study warrant further studies in this field.
Clinical Trial Registration: The study was registered in the Iranian Clinical Trial Registry Center (http://www.irct.ir) with the registration code: IRCT2015081423426N1.
Funding: The authors received no financial support for the research, authorship, and/or publication of this article.
References
Gupta D, Lis CG, GrutschJF. The relationship between cancer-related fatigueand patient satisfaction with
quality of life in cancer. J Pain Symptom Manage. 2007; 34(1):40-7. Doi:
1016/j.jpainsymman.2006.10.012. PMID: 175321791
Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, Eisenberger MA, et al. Cancer-related
fatigue. Clinical Practice Guidelines in Oncology. J NatlComprCancNetw. 2007; 5(10):1054-78.Review.
PMID: 18053429
Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer-related fatigue: inevitable,
unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol.
; 11(8):971-5. Doi: 10.1023/A: 1008318932641. PMID: 11038033
Atkins MB, MierJW, Parkinson DR, Gould JA, BerkmanEM, Kaplan MM. Hypothyroidism after treatment
with interleukin-2 and lymphokine-activated killer cells. N Engl J Med. 1988; 318(24):1557- 63. Doi:
1056/NEJM198806163182401. PMID: 3259674
Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P et al. Fatigue during head-and- neck radiotherapy: prospective study on 117 consecutive patients. Int J RadiatOncolBiol Phys. 2007;
(2):403-15. Doi: 10.1016/j.ijrobp.2007.01.024
LittlewoodTJ, Kallich JD, San Miguel J, Hendricks L, Hedenus M. Efficacy of darbepoetinalfa in
alleviating fatigue and the effect of fatigue on quality of life in anemic patients with lymphoproliferative
malignancies. J Pain Symptom Manage. 2006; 31(4):317-25. Doi: 10.1016/j.jpainsymman.2005.08.013.
PMID: 16632079
Lis CG, Rodeghier M, GrutschJF, Gupta D. Distribution and determinants of patient satisfaction in
oncology with a focus on health related quality of life. BMC Health Serv Res. 2009; 9: 19. Doi:
1186/1472-6963-9-190. PMID: 19845942. PMCID: PMC2770467
Curt GA, Breitbart W, Cella D, Groopman JE HorningSJ, Itri LM, et al. Impact of cancer-related fatigue on
the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000; 5(5):353-60. Doi:
1634/theoncologist.5-5-353. PMID: 11040270
VogelzangNJ, Breitbart W, Cella D, Curt GA, Groopman JE, HorningSJ, et al. Patient, caregiver, and
oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue
Coalition. SeminHematol. 1997; 34(3 Suppl 2):4-12. PMID: 9253778
Jereczek-Fossa BA, MarsigliaHR, Orecchia R. Radiotherapy-related fatigue. Crit Rev OncolHematol.
; 41(3):317-25. Review. Doi: 10.1016/S1040-8428(01)00143-3
Malik UR, Makower DF, Wadler S. Interferon-mediated fatigue. Cancer. 2001 Sep 15; 92(6 Suppl):1664-8.
Doi: 10.1002/1097-0142(20010915)92:6+<1664: AID-CNCR1494>3.0.CO;2-9
Barton DL, Liu H, Dakhil SR, et al. Wisconsin Ginseng (Panaxquinquefolius) to Improve Cancer-Related
Fatigue: A Randomized, Double-Blind Trial, N07C2. JNCI Journal of the National Cancer Institute. 2013;
(16):1230-8. Doi: 10.1093/jnci/djt181
Wang XS. Pathophysiology of cancer-related fatigue.Clin J OncolNurs. 2008 Oct; 12(5 Suppl):11-20. Doi:
1188/08.CJON.S2.11-20. PMID: 18842520. PMCID: PMC3281752
Horneber M, Fischer I, Dimeo F, RüfferJU, Weis J. Cancer-Related Fatigue: Epidemiology, Pathogenesis,
Diagnosis, and Treatment. DeutschesÄrzteblatt International. 2012; 109(9):161-172. PMID: 22461866.
PMCID: PMC3314239
Azab KS, et al: Royal jelly modulates oxidative stress and tissue injury in gamma irradiated male wister
albino rats.N Am J Med Sci. 2011 Jun; 3(6):268-76. Doi: 10.4297/najms.2011.3268. PMID: 22540097.
PMCID: PMC3336918
Karadeniz A, Simsek N, Karakus E, Yildirim S, Kara A, Can I, et al: Royal JellyModulates Oxidative
Stress and Apoptosis in Liver and Kidneys of Rats Treated with Cisplatin. Oxid Med Cell Longev. 2011;
: 981793. Doi: 10.1155/2011/981793.
Silici S, Ekmekcioglu O, Kanbur M, Deniz K. The protective effect of royal jelly against cisplatin-induced
renal oxidative stress in rats. World J Urol. 2011 Feb; 29(1):127-32. Doi: 10.1007/s00345-010-0543-5.
PMID: 20369241
Cemek M, Yılmaz F, Büyükokuroğlu ME, Büyükben A, Aymelek F, Ayaz A. Serum and liver tissue bio- element levels, and antioxidant enzyme activities in carbon tetrachloride-induced hepatotoxicity: protective
effects of royal jelly. J Med Food. 2012 Aug; 15(8):747-52. Doi: 10.1089/jmf.2012.0010. PMID: 22510102
Othman NH: Honey and Cancer: Sustainable Inverse Relationship Particularly for Developing Nations-A
Review. Evidence-Based Complementary and Alternative Medicine. 2012, Article ID: 410406
Pourahmad M, Sobhanian S. Effect of Honey on the Common Cold. Archives of Medical Research; 2009,
Vol 40, Issue 3, Pages 224–225. Doi: 10.1016/j.arcmed.2009.01.001. PMID: 19427976
Al-Waili NS, Al-Waili TN, Al-Waili AN, Saloom KS. Influence of Natural Honey on Biochemical and
Hematological Variables in AIDS: A case study. Scientific World Journal. 2006 Feb 2; 6:1985-9. Doi:
1100/tsw.2006.331. PMID: 17369997
Oka H, Emori Y, Kobayashi N, Hayashi Y, Nomoto K.Suppression of allergic reactions by royal jelly in
association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses.
Int Immunopharmacol. 2001 Mar; 1(3):521-32. Doi: 10.1016/S1567-5769(00)00007-2
Nakaya M, Onda H, Sasaki K, Yukiyoshi A, Tachibana H, Yamada K. Effects of royal jelly on Bisphenol
A-induced proliferation of human breast cancer cells. BiosciBiotechnolBiochem. 2007 Jan; 71(1):253-5.
Doi: 10.1271/bbb.60453. PMID: 17213647
Townsend GF, Morgan JF, Tolnai S, Hazlett B, Morton HJ, ShuelRW.Studies on the in vitro antitumor
activity of fatty acids. I. 10-Hydroxy-2-decenoic acid from royal jelly. Cancer Res. 1960; 20:503-10.
PMID: 13839101
Tamura T, Fujii A, Kuboyama N. Antitumor effects of royal jelly (RJ).Nihon YakurigakuZasshi. 1987 Feb;
(2):73-80. Doi: 10.1254/fpj.89.73. PMID: 3570105
Campos MP, Hassan BJ, Riechelmann R, Del Giglio A. Cancer-related fatigue: a review. Rev Assoc Med
Bras. 2011 Mar-Apr; 57(2):211-9. Doi: 10.1590/S0104-42302011000200021. PMID: 21537710
Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, et al. Phase III, randomized, double- blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue. North Central
Cancer Treatment Group NCCTG-N05C7 trial. J ClinOncol 2010; 28:3673. Doi:
1200/JCO.2010.28.1444. PMID: 20625123, PMCID: PMC2917307
Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK et al. Sleep/Wake patterns of
individuals with advanced cancer measured by ambulatory polysomnography. J ClinOncol. 2008;
(15):2464-72. Doi: 10.1200/JCO.2007.12.2135. PMID: 18487566
Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR, et al. Effect of sertraline on
symptoms and survival in patients with advanced cancer, but without major depression: a placebo- controlled double-blind randomised trial. Lancet Oncol. 2007; 8(7):603-12. Doi: 10.1016/S1470- 2045(07)70148-1
Palesh O, Mustian KM, Roscoe JA, et al. Effect of paroxetine on depression and insomnia in 547 fatigued
cancer patients undergoing chemotherapy (abstract). J ClinOncol 2008; 26:502s.
Barton DL, SooriGS, Bauer BA, Sloan JA, Johnson PA, Figueras C, et al. Pilot study of
Panaxquinquefolius (American ginseng)to improve cancer-related fatigue: a randomized, double-blind,
dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 2010 Feb; 18(2):179-87. Doi:
1007/s00520-009-0642-2. PMID: 19415341. PMCID: PMC3911883
JeongJS, RyuBH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-Tang for Cancer-Related Fatigue: A
Pilot Randomized Clinical Trial. Integr Cancer Ther. 2010 Dec; 9(4):331-8. Doi:
1177/1534735410383170. PMID: 21059621
Kamakura M, Mitani N, Fukuda T, Fukushima M. Antifatigue effect of fresh royal jelly in mice. J
NutrSciVitaminol (Tokyo). 2001 Dec; 47(6):394-401. Doi: 10.3177/jnsv.47.394
Fauzi AN, Norazmi MN, Yaacob NS. Tualang honey induces apoptosis and disrupts the mitochondrial
membrane potential of human breast and cervical cancer cell lines. Food ChemToxicol. 2011 Apr;
(4):871-8. Doi: 10.1016/j.fct.2010.12.010. PMID: 21167897
Zidan J, Shetver L, Gershuny A, Abzah A, Tamam S, Stein M, Friedman E.Prevention of ChemotherapyInduced Neutropenia by Special Honey Intake.MedOncol. 2006; 23(4):549-52. Doi: 10.1385/mo:23:4:549
Erem C, Deger O, Ovali E, BarlakY.The Effects of Royal Jelly on Autoimmunity in Graves' Disease.
Endocrine. 2006; 30(2):175-83. Doi: 10.1385/ENDO:30:2:175
Yang XY, Yang DS, Wei-Zhang, Wang JM, Li CY, Hui-Ye, et al. 10-Hydroxy-2-decenoic acid from Royal
jelly: A potential medicine for RA. J Ethnopharmacol. 2010 Mar 24; 128(2):314-21. Doi:
1016/j.jep.2010.01.055. PMID: 20138211
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
